Natriumchlorid Aguettant (Sodium Chloride)

After intravenous administration, sodium chloride dissociates into sodium and chloride ions. These ions increase extracellular osmolarity, drawing water into the vascular space, expanding plasma volume, and restoring normal serum concentrations of sodium and chloride, which are essential for nerve function, muscle contraction, and overall fluid balance.

The dose of Natriumchlorid Aguettant is determined by the prescribing clinician based on the patient’s fluid loss, electrolyte status, weight, and clinical condition. Healthcare professionals calculate the appropriate volume and rate of infusion to achieve the desired therapeutic effect.

Safety data for Natriumchlorid Aguettant in pregnancy and lactation are limited. Because it is a basic electrolyte solution, it may be used when clearly needed, but the prescriber should weigh potential benefits against any unknown risks and consider alternative therapies if appropriate.

To order Natriumchlorid Aguettant, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Natriumchlorid Aguettant is a simple isotonic saline solution that provides only sodium and chloride, unlike balanced crystalloids that contain additional electrolytes such as potassium or bicarbonate. It is preferred when a pure sodium‑chloride replacement is required, while balanced solutions may be chosen to reduce the risk of hyperchloremic acidosis.

Store Natriumchlorid Aguettant at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from direct sunlight, moisture and extreme temperatures. Do not freeze the solution, and inspect the container for any signs of damage before use.

Natriumchlorid Aguettant is administered intravenously. The solution is drawn into a sterile syringe or infusion set and infused through a peripheral or central vein. The rate of infusion is set by the clinician according to the patient’s fluid needs and monitored throughout the administration.

Serious risks include severe hypernatremia or hyperchloremia, which can lead to neurological disturbances, cardiac arrhythmias, or volume overload causing pulmonary edema. Allergic reactions, including anaphylaxis, are also possible. Prompt monitoring of electrolytes and fluid status helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride solutions should avoid Natriumchlorid Aguettant. Caution is advised in individuals with severe renal impairment, uncontrolled heart failure, or conditions predisposing them to fluid overload, as excessive administration may exacerbate these disorders.